HCID 1487532, compound → HCID 68408078, compound

HRID 888034Notes

Reaction equation

HRID 888034 reaction equation
[C:1]([O:5][C:6]([NH:8][C:9]1[CH:14]=[CH:13][CH:12]=[CH:11][C:10]=1[NH:15][C:16](=[O:32])[C:17]1[CH:22]=[CH:21][C:20](B2OC(C)(C)C(C)(C)O2)=[CH:19][CH:18]=1)=[O:7])([CH3:4])([CH3:3])[CH3:2].Cl[C:34]1[S:35][C:36]([CH2:39][N:40]2[CH2:45][CH2:44][CH2:43][CH2:42][CH2:41]2)=[CH:37][N:38]=1>>[C:1]([O:5][C:6]([NH:8][C:9]1[CH:14]=[CH:13][CH:12]=[CH:11][C:10]=1[NH:15][C:16](=[O:32])[C:17]1[CH:18]=[CH:19][C:20]([C:34]2[S:35][C:36]([CH2:39][N:40]3[CH2:41][CH2:42][CH2:43][CH2:44][CH2:45]3)=[CH:37][N:38]=2)=[CH:21][CH:22]=1)=[O:7])([CH3:2])([CH3:4])[CH3:3]

Participants

3

Procedure

Using an analogous procedure to that described in Method 44, N-(2-t-butoxycarbonylaminophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide (Method 13, 219 mg, 0.5 mmol) was reacted with 1-[(2-chloro-1,3-thiazol-5-yl)methyl]piperidine (108 mg, 0.5 mmol) to give the title compound (271 mg, >100%) which was carried through the next step; Mass Spectrum: M+H+ 493.

Sources & evidence

ORD record
ord-2c6d0f965d0947f289d813182d83ec96
Source dataset
uspto-grants-2012_08
Patent number
US08247562B2

Reaction notes

Loading…